ContractJoint Filing Agreement • February 11th, 2010 • Mangano Ross J • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 9 to Schedule 13G need be filed with respect to ownership by each of the undersigned of shares of common stock of BioSante Pharmaceuticals, Inc.
